LeMaitre Vascular To Present At The Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference On March 1st

BURLINGTON, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Lazard Capital Markets 5 th Annual Medical Technology Snowbird Conference at the Snowbird Ski and Summer Resort in Snowbird, Utah. JJ Pellegrino, Chief Financial Officer, will provide an update on the Company on Friday March 1, 2013.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Over-the-Wire LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt and The UnBalloon. Additional information can be found at http://www.lemaitre.com .

The LeMaitre Vascular, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10015
CONTACT: LeMaitre Vascular, Inc.         Investor Relations         +1-781-221-2266         http://www.lemaitre.com         http://www.lemaitre.com/investor

LeMaitre Vascular, Inc. Logo

If you liked this article you might like

5 Small-Caps That Could Be Big Performers

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

Sales Are Flowing for Small-Cap Biotech

Jim Cramer's 'Mad Money' Recap: Here's What's Important Next Week

Insider Trading Alert - HIL, PCRX And LMAT Traded By Insiders